Koski Christine L. Just Picked Up Sun Hydraulics Corp (NASDAQ:SNHY) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Sun Hydraulics Corp (NASDAQ:SNHY) reported that Koski Christine L. has picked up 2,505,476 of common stock as of 2017-02-07.
The acquisition brings the aggregate amount owned by Koski Christine L. to a total of 2,505,476 representing a 9.3% stake in the company.
For those not familiar with the company, Sun Hydraulics Corporation (Sun) designs and manufactures screw-in hydraulic cartridge valves and manifolds, which control force, speed and motion as integral components in fluid power systems. The Company operates through manufacturing and distribution of hydraulic components segment. The Company, at components level, designs and manufactures screw-in hydraulic cartridge valves, manifolds, and integrates fluid power packages and subsystems for industrial and mobile markets. It is also engaged in power controls and vehicle technologies lines of business. The Company sells its products across the globe through subsidiaries and independent distributors. It has operations in the United States, England, Germany, France, South Korea, China and India. Sun’s standard cartridge valves and manifolds are offered in multiple versions and size ranges. Its subsidiaries include Sun Hydraulik Holdings Limited, Sun Hydraulics Korea Corporation, High Country Tek, Inc. and Enovation Controls, LLC.
A glance at Sun Hydraulics Corp (NASDAQ:SNHY)’s key stats reveals a current market capitalization of 1.03 billion based on 26.93 million shares outstanding and a price at last close of $38.58 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2012-09-10, Dangel picked up 10,000 at a purchase price of $24.92. This brings their total holding to 13,349 as of the date of the filing.
On the sell side, the most recent transaction saw Koski unload 23,410 shares at a sale price of $31.84. This brings their total holding to 293,519.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Sun Hydraulics Corp (NASDAQ:SNHY) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Here’s Who Just Picked Up Ameresco Inc. (NYSE:AMRC) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Ameresco Inc. (NYSE:AMRC) reported that Sakellaris George P. has picked up 22,918,361 of common stock as of 2017-02-07.
The acquisition brings the aggregate amount owned by Sakellaris George P. to a total of 22,918,361 representing a 49.3% stake in the company.
For those not familiar with the company, Ameresco, Inc. is a provider of energy efficiency, infrastructure upgrades, asset sustainability and renewable energy solutions for businesses and organizations. The Company’s principal service is the development, design, engineering and installation of projects. Its U.S. Regions, U.S. Federal and Canada segments offer energy efficiency products and services, which include the design, engineering and installation of equipment and other measures; renewable energy solutions and services, and operations and maintenance (O&M) services. The Company’s Small-Scale Infrastructure segment sells electricity, processed landfill gas (LFG), heat or cooling, produced from renewable sources of energy and generated by small-scale plants that it owns. The Company’s Small-Scale Infrastructure segment also includes certain small-scale plants developed for customers. The All Other segment offers enterprise energy management services, consulting services and integrated-photovoltaic (PV).
A glance at Ameresco Inc. (NYSE:AMRC)’s key stats reveals a current market capitalization of 222.55 million based on 28.06 million shares outstanding and a price at last close of $4.95 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-08-15, Miller picked up 500 at a purchase price of $5.05. This brings their total holding to 4,000 as of the date of the filing.
On the sell side, the most recent transaction saw Gagnon unload 1,781 shares at a sale price of $6.17. This brings their total holding to 91,325.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Ameresco Inc. (NYSE:AMRC) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Salon Media Group, Inc. (OTCMKTS:SLNM) is Attracting Smart Money
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Catabasis Pharmaceuticals Inc. (NASDAQ:CATB) reported that Spear Point Capital Management Llc. has picked up 190,154,289 of common stock as of 2017-02-07.
The acquisition brings the aggregate amount owned by Spear Point Capital Management Llc. to a total of 190,154,289 representing a 69.05% stake in the company.
For those not familiar with the company, Catabasis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics based on its Safely Metabolized and Rationally Targeted (SMART), a linker drug discovery platform. The SMART linker drug discovery platform enables to engineer product candidates that can modulate multiple targets in a disease. The Company’s primary focus is on treatments for rare diseases. The Company is also developing other product candidates for the treatment of lipid disorders. The Company’s CAT-1004 is a SMART linker conjugate of salicylate, a non-steroidal anti-inflammatory drug, and the omega-3 fatty acid docosahexaenoic acid (DHA), a naturally occurring unsaturated fatty acid with anti-inflammatory properties.
A glance at Salon Media Group, Inc. (OTCMKTS:SLNM)’s key stats reveals a current market capitalization of 5.72 million based on 76.27 million shares outstanding and a price at last close of $0.100 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-06-04, Hambrecht picked up 10,261,429 at a purchase price of $0.35. This brings their total holding to 27,174,322 as of the date of the filing.
On the sell side, the most recent transaction saw Warnock unload 10,261,429 shares at a sale price of $0.35. This brings their total holding to 34,878,281.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Salon Media Group, Inc. (OTCMKTS:SLNM) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Svlsf V, Llc. is Buying Catabasis Pharmaceuticals Inc. (NASDAQ:CATB) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Catabasis Pharmaceuticals Inc. (NASDAQ:CATB) reported that Svlsf V, Llc. has picked up 2,857,667 of common stock as of 2017-02-07.
The acquisition brings the aggregate amount owned by Svlsf V, Llc. to a total of 2,857,667 representing a 15.3% stake in the company.
For those not familiar with the company, Catabasis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics based on its Safely Metabolized And Rationally Targeted (SMART), a linker drug discovery platform. The SMART linker drug discovery platform enables to engineer product candidates that can modulate multiple targets in a disease. The Company’s primary focus is on treatments for rare diseases. The Company is also developing other product candidates for the treatment of lipid disorders. The Company’s CAT-1004 is a SMART linker conjugate of salicylate, a non-steroidal anti-inflammatory drug, and the omega-3 fatty acid docosahexaenoic acid (DHA), a naturally occurring unsaturated fatty acid with anti-inflammatory properties.
A glance at Catabasis Pharmaceuticals Inc. (NASDAQ:CATB)’s key stats reveals a current market capitalization of 23.71 million based on 18.65 million shares outstanding and a price at last close of $1.23 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-06-30, George picked up 12,422 at a purchase price of $12.00. This brings their total holding to 90,764 as of the date of the filing.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Catabasis Pharmaceuticals Inc. (NASDAQ:CATB) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Huckleberry Investments Llp. Picked Up Jrjr33 Inc. (NYSEMKT:JRJR) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Jrjr33 Inc. (NYSEMKT:JRJR) reported that Huckleberry Investments Llp. has picked up 3,441,232 of common stock as of 2017-02-07.
The acquisition brings the aggregate amount owned by Huckleberry Investments Llp. to a total of 3,441,232 representing a 8.75% stake in the company.
For those not familiar with the company, JRjr33, Inc. (JRJR), formerly CVSL Inc., offers a platform of direct-to-consumer brands. The Company operates through the segments, which include Gourmet Food, Nutritional and Wellness, Home Decor, Publishing and Printing, and Other. The Gourmet Food Products segment consists of operations related to the production and sale of hand-crafted spices, oils and other food products from around the world. The Home Decor segment consists of operations related to the production and sale of premium hand-crafted baskets, and the selling of products for the home, including pottery, cleaning, health, beauty, home, outdoor and customizable vinyl expressions for display. The Nutritionals and Wellness segment consists of operations related to the selling of nutritional supplements and skin care products.
A glance at Jrjr33 Inc. (NYSEMKT:JRJR)’s key stats reveals a current market capitalization of 31.92 million based on 39.38 million shares outstanding and a price at last close of $0.779 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-12-16, Randall picked up 4,890 at a purchase price of $1.16. This brings their total holding to 27,000 as of the date of the filing.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Jrjr33 Inc. (NYSEMKT:JRJR) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Guess Who Just Picked Up Ocular Therapeutix Inc. (NASDAQ:OCUL) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Ocular Therapeutix Inc. (NASDAQ:OCUL) reported that Svlsf V, Llc. has picked up 1,605,207 of common stock as of 2017-02-07.
The acquisition brings the aggregate amount owned by Svlsf V, Llc. to a total of 1,605,207 representing a 6.5% stake in the company.
For those not familiar with the company, Ocular Therapeutix, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapies for diseases and conditions of the eye using its hydrogel platform technology. The Company’s bioresorbable hydrogel based product candidates are designed to provide sustained delivery of therapeutic agents to the eye. Its hydrogel is a bioresorbable formulation of polyethylene glycol (PEG), which when constituted with water takes on a gelatinous consistency. The Company’s product pipeline includes marketed candidate ReSure Sealant and products under development, such as OTX-DP, OTX-TP, OTX-MP and anti-VEGF hydrogel depot. The Company’s lead product candidates are OTX-DP and OTX-TP. The OTX-DP product candidate incorporates the corticosteroid dexamethasone as an active pharmaceutical ingredient in its punctum plug.
A glance at Ocular Therapeutix Inc. (NASDAQ:OCUL)’s key stats reveals a current market capitalization of 198.42 million based on 28.76 million shares outstanding and a price at last close of $6.89 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-12-15, Sawhney picked up 45,300 at a purchase price of $7.85. This brings their total holding to 677,390 as of the date of the filing.
On the sell side, the most recent transaction saw Fortune unload 9,470 shares at a sale price of $17.16. This brings their total holding to 112,060.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Ocular Therapeutix Inc. (NASDAQ:OCUL) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Here’s Who Just Picked Up Kalvista Pharmaceuticals Inc. (NASDAQ:KALV) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Kalvista Pharmaceuticals Inc. (NASDAQ:KALV) reported that Svlsf V, Llc. has picked up 2,579,490 of common stock as of 2017-02-07.
The acquisition brings the aggregate amount owned by Svlsf V, Llc. to a total of 2,579,490 representing a 26.6% stake in the company.
For those not familiar with the company, KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The Company has developed a portfolio of small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME). The Company is developing a plasma kallikrein inhibitor, which is administered directly into the eye. The Company is engaged in advancing several product candidates developed from its portfolio into early clinical trials. The Company is progressing additional oral candidates towards regulatory preclinical studies. The Company’s HAE product candidate, KVD818, is an inhibitor of plasma kallikrein. The Company has initiated clinical testing of KVD818 in a Phase I clinical trial. It has completed an open-label single ascending dose Phase I trial in DME patients with KVD001.
A glance at Kalvista Pharmaceuticals Inc. (NASDAQ:KALV)’s key stats reveals a current market capitalization of 70.68 million based on 9.93 million shares outstanding and a price at last close of $7.16 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-04-14, Cha picked up 7,364 at a purchase price of $5.00. This brings their total holding to 4,204,562 as of the date of the filing.
On the sell side, the most recent transaction saw Renzi unload 10,000 shares at a sale price of $3.70. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Kalvista Pharmaceuticals Inc. (NASDAQ:KALV) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Udvar-hazy Steven F. Just Picked Up Air Lease Corp. (NYSE:AL) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Air Lease Corp. (NYSE:AL) reported that Udvar-hazy Steven F. has picked up 7,030,593 of common stock as of 2017-02-06.
The acquisition brings the aggregate amount owned by Udvar-hazy Steven F. to a total of 7,030,593 representing a 6.7% stake in the company.
For those not familiar with the company, Air Lease Corporation is an aircraft leasing company. The Company is principally engaged in purchasing new commercial jet transport aircraft directly from aircraft manufacturers, such as The Boeing Company (Boeing) and Airbus S.A.S. (Airbus), and leasing those aircraft to airlines across the world. Along with its leasing activities, the Company sells aircraft from its operating lease portfolio to third parties, including other leasing companies, financial services companies and airlines. The Company also provides fleet management services to investors and owners of aircraft portfolios for a management fee. The Company provides aircraft to airline customers in various markets, such as Asia, the Pacific Rim, Latin America, the Middle East, Europe, Africa and North America. The Company owns approximately 240 aircraft, including over 180 single-aisle narrowbody jet aircraft, approximately 40 twin-aisle widebody jet aircraft and over 20 turboprop aircraft.
A glance at Air Lease Corp. (NYSE:AL)’s key stats reveals a current market capitalization of 3.86 billion based on 102.84 million shares outstanding and a price at last close of $37.00 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-08-24, Udvar-Hazy picked up 3,000 at a purchase price of $30.23. This brings their total holding to 1,209,558 as of the date of the filing.
On the sell side, the most recent transaction saw Khatibi unload 10,871 shares at a sale price of $35.09. This brings their total holding to 143,616.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Air Lease Corp. (NYSE:AL) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.